1 Paterson Institute for Cancer Research, Christie
Hospital and Holt Radium Institute, Manchester, M20 9BX, United
Kingdom
2 Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie
an der Universität Hamburg, Martinistraße 52, 2000 Ham burg 20,
FRG
3 Biogen, 46 Route des Acacias, 1227 Geneva, Switzerland
4 Present address: U niversitätskrankenhaus Eppendorf, II. Medizinische
Klinik, Abteilung für Klinische Chemie, Martinistr. 52, D-2000 Hamburg
20, FRG
* This work was supported by the Cancer Research Campaign, United
Kingdom, and the Deutsche Forschungsgemeinschaft.
The Heinrich-Pette-Institut is financially supported by the Free
Hanseatic City of Hamburg
and the Bundesministerium für Jugend, Familie, Frauen und Gesundheit
A. Introduction
It is widely accepted that most naturally occurring leukemias are
monoclonally derived from multipotent stem cells [5- 7, 17], but
the genetic changes leading to their transformation are poorly understood.
A useful system in which to study the various processes occurring
during leukemogenesis is offered by nonleukemic, multipotent stem
cell lines (FDCPmix) established from murine long-term marrow cultures
[20]. These cells grow continuously in vitro in the presence of
11-3, but they can also be induced to differentiate into mature
granulocytes, macrophages, erythrocytes, and occasionally megakaryocytes,
eosinophils, and mast cells by serum factors [20] or in association
with marrow stromal cells [20] or certain embryonic mesenchymal
cell lines [18]. Recent data have shown that hematopoietic growth-fac
tor-dependent progenitor cell lines ac quire growth-factor-independent
growth and tumorigenicity when they are infected with retroviral
vectors containing genes coding for 11-3 or GM-CSF [10, 11] .However
, these studies have been restricted to cell lines which are blocked
in differentiation and may therefore not reflect the alterations
that occur in stem cells during leukemogenesis. To determine the
effects of aberrant expression of 11-3 in differentiation-inducible
stem cells we infected FDCPmix cells with a selectable retroviral
vector carrying the cDNA of 11-3.
B. Materials and Methods
I. Vector Construction and Virus-producing Cell Lines
A cDNA clone of 11-3 (kindly provided by N. Gough, Melbourne)
was subcloned into the MPSV -based M3neo vector [9, 10] and used
for transfections into the amphotropic helper cell line, PA 317
[16], to produce infectious M3 MuV particles. Cell clone psi2 mos-
1 no.4 con taining the neo MPSV mas deletion vector [22] was used
to infect PA 317 in order to obtain amphotropic pseudotypes necessary
for the infection of the ecotropicvirus producing FDCPmix cell lines
[23]. Cell clones with titres of 10 high 3-10 high 5 for MuVand
10 high 5-10 high 8 GTU for mos-l and with intact proviral genomes
were used for co-cultivation experiments.
II. Cells
Virus-producing cell lines were kept in minimal essential medium
supplemented with 10% fetal calf serum. Hematopoietic cell lines
were maintained in Iscove's modified Dulbecco's medium, supplemented
with 20% horse serum and Wehi 3BD-conditioned medium (WEHI CM) as
a source of multi-CSF (I1-3) at a concentration that stimulated
optimal cell growth.
III. Viral Infection and Selection Procedure
10 high 5 FDCPmix cells were inoculated onto subconfluent irradiated
(20 Gy) virusproducer cell lines. Various FDCPmix cell lines were
used. Two days later, the loosely adherent cells and cells in suspension
were harvested, washed, and resuspended at about 10 high 5 cells/ml.
After 2 days of culture, G418 was added to a final concentration
of 1 mg/ml and the cells were subcultured as appropriate. Non-virus-infected
cells died within 7 days but cells which had been co-cultured on
the M3MuV and M3neo-producer cell lines continued to proliferate
in the presence of the G418. About 2 weeks after selection with
G418, the cells were cloned in soft agar in the presence of I1-3,
and individual colonies were isolated and expanded from three different
FDCPmix cell lines.
IV. Determination of 11-3 Activity
M3-MuV infected cells (10 high 6) were washed twice to remove
residual I1-3 and incubated without WEHI-CM for 48 h. The supernatant
was used as such or concentrated tenfold via Amicon filtration (exclusion
mol. wt. < 10000), dialyzed, and tested for stimulatory activity
on indicator cell lines by determining [³H] thymidine incorporation.
Half-maximal stimulation of FDCP2 cells by either WEHI-CM or recombinant
murine I1-3 was defined as 50 U /ml.
V. Growth Inhibition Assay
One of the clones of FDCPmix infected with M3MuV was grown at
high density in the absence of 11-3. Cells were washed twice in
medium without I1-3 and plated, 1 x 10 high 4 cells/well, into 96-well
plates. Dilutions of the antiserum of preimmune rabbit serum ranged
from 1: 20 to : 10240 final. 30 h after initiation, 0.5 µCi [³³]
thymidine was added for 14 h. Cells were harvested onto filters,
using a cell harvester (Titertec), and counted.
VI. Colony Assay
10³ control uninfected cells and cells infected with M3neo virus
alone or M3MuV were plated in soft agar in culture conditions which
allow the expression of multiple hematopoietic lineages [19]. Individual
colonies were isolated after 10 days of growth, cytospin preparations
made, and the cells stained with benzidine plus May-Grunwald Giemsa.
At least 30 colonies were examined from each group.
VII. Marrow Stromal Cell Culture
Stromal cell cultures derived from bone marrow were irradiated
[20, 21] and used as a supportive stroma for the growth of the FDCPmix
cells, either uninfected, or M3MuV or M3neo infected. Between 2
x 10 high 6 and 10 high7 FDCPmix cells were cocultured with the
marrow stromal cells. At various times after seeding of marrow stroma
by the FDCPmix cells, cytospin preparations of the nonadherent cells
were performed and the cells stained with May-Grunwald Giemsa.
VIII. Diffusion Chamber Culture
After two washes, aliquots of 5 x 10 high 5 FDCPmix cells, infected
with either M3MuV or M3Neo, were inoculated into each diffusion
chamber (DC). These were then inserted intraperitoneally into male
CBA mice. After 7 days of culture the animals were killed; the chambers
were removed and shaken for 40 min in a 0.5% Pronase solution (Merck).
The resulting cell suspensions were counted for the total number
of nucleated cells. Cytospin preparations were made and the cells
were classified according to morphological criteria [12].
IX. Nucleic Acid Analysis
Cellular DNA was isolated and restricted by standard techniques
and separated on agarose gels. Total RNA was isolated as previously
described [2] and transferred to Gene Screen Plus (NEN) after denaturation
with glyoxal and dimethylsulfoxide and electrophoresis through agarose
gels [14]. Nucleic acids were transferred to Gene Screen Plus (NEN)
and hybridized under the conditions recommended by the manufacturer,
with probes labeled as previously described [4]. Probes used for
analysis included an EcoRI-NcoI fragment of pMu21A containing the
11-3 cDNA clone (N. Gough, unpublished), the BglIII-BamHI fragment
of pAG60 containing the coding region of the neo gene [3], and the
PY80B probe specific for the murine Y -chromosome [1].
X. In Vivo Administration of FDCPmix Cells
Uninfected and A4/M3neo cells (cultured with 11-3) and A4/M3MuV
cells (cultured without 11-3) were suspended in Fischer's medium
at an appropriate cell concentration. The cells were injected i.
v. in syngeneic B6D2Fl mice that had received 10 Gy, prior to inoculation
of the cells.
C. Results
I. Virus Integration, Gene Expression, and Il-3 Secretion
Following infection and selection in liquid culture the cells were
cloned in soft agar in the presence of 0418. Individual clones were
isolated and cultured for further analysis. Analysis of the virus
insertion sites revealed that the resulting cell lines were monoclonal
( data not shown). The I1-3 gene was expressed in the MuV infected
FDCPmix cells, as shown by Northern analysis (data not shown). Conditioned
medium of the M3MuV-infected cells growing in the absence of Il-3
contained between 4 and 50 units of Il-3 activity per ml.
II. Density-dependent Growth Autonomy
All M3MuV infected cell lines could grow in high density without
Il-3, whereas the uninfected FDCPmix cells and the M3neo-infected
cells died in the absence of growth factor. Cloning of FDCPmix M3MuV-infected
cells in soft agar resulted in nonlinear, density-dependent growth
in the absence ofI1-3 and in nearly linear growth in the presence
of I1-3 (Fig. 1). Growth of the M3MuV-infected cells could be blocked
by neutralizing antisera to I1-3 (Fig. 2).
Fig.l. Clonability of FDCPmix M3MuV-infected cells as
a function of cell density. Uninfected FDCPmix cells with (black
square ) and without (white square) Il-3; M3neo-infected FDCPmix
cells with (black ring) and without ( white ring ) I1-3; M3MuV -infected
FDCPmix cells with ( black triangle ) and without ( white triangle
) I1-3
Table I. Colony formation by control and
infected FDCPmix cells
Table 2. In vivo administration of FDCPmix cells
III. Differentiation Induction
M3MuV-infected stem cell lines retained their capacity to undergo
differentiation in response to serum factors or marrow stromal cells.
In the mixed colony assay the plating efficiency was unaltered and
the colonies produced contained maturing granulocytes and macrophages
(Table 1). However, erythroid cells were rarely seen, and the balance
between immature and mature granulocytes was changed in favor of
immature cells (Table 1, Fig. 3). The same was true when the cells
were co-cultured with marrow stromal cells (data not shown). Culture
of M3MuV-infected FDCPmix cells in vivo in the DC led to an increase
of immature and mature granulocytes and macrophages similar to the
in vitro observations. In addition, erythroblasts were also found
in the DC (data not shown).
Fig.2. Growth inhibition of FDCPmix M3MuV-infected cells
by anti-II-3 antiserum. (Black ring )Growth medium with rabbit anti-Il-3
antiserum; ( white ring ) growth medium with rabbit preimmune serum;
( white square ) growth medium without antiserum or preimmune serum
IV. In Vivo Administration of FDCPmix MuV-infected Cells
When FDCPmix M3MuV-infected cells were injected into sublethally
irradiated syngeneic mice, the animals developed a five- to ten
fold increase in the spleen weight, an increase in peripheralleukocytes,
and a decreased hematocrit (Table 2). Morphological analysis of
cells present in the spleen and peripheral blood of a representative
mouse (Fig.4) showed the following differential: spleen (blood)
16% (2)% blasts, 21% (10)% promyelocytes/myelocytes, 55% (75)% metamyelocytes
and polymorphonuclear granulocytes, 5% (1)% nucleated erythroid
cells, 3% (12)% other. The animals died within 2 months, whereas
control mice, in jected with stem cells containing the M3neo vector,
showed no evidence of disease 6 months later. To determine the origin
of the disease, cytogenetic analysis of cells in the spleen of the
leukemic mice was performed. Initially, 80% -100% of the mitoses
were of donor origin and possessed a normal (donor) male karyotype.
Subsequently, however, spleen, bone marrow, and blood cells were
of recipient origin, as revealed by Southern blotting (data not
shown). Furthermore, the viral integration sites of cell lines recovered
from leukemic animals were different from the original viral insertion
site of the donor FDCPmix cells ( data not shown).
Fig. 3 a, b. Mixed colony formation by control and
infected FDCPmix cells.
a Parental FDCPmix cells;
b FDCPmix M3MuV-infected cells
Fig.4a-d. In vivo administration of FDCPmix M3MuVinfected
cells.
a FDCP-mix M3MuV-infected cells;
b normal peripheral blood cells;
c peripheral blood cells from leukemic mouse;
d spleen cells from leukemic mouse
D. Discussion
The present results show that infection of multipotent 11-3-dependent
stem cells with a retroviral vector containing the 11-3 gene confer
density-dependent autocrine stimulation of growth without blocking
differentiation, but with a change of the balance between differentiation
and proliferation in favor of proliferation. From these data we
conclude that inappropriate expression of 11-3 may play an important
role in the multistep pathogenesis of leukemia. When the 11-3 infected
cells were injected into sublethally irradiated syngeneic mice,
the animals developed a myeloproliferative disease. However, the
precise role of the injected cells remains to be determined. Analysis
of spleen and blood cells of the leukemic mice revealed that the
proliferating cells were initially derived from the transplanted
stem cells but were subsequently of recipient origin. Furthermore,
the viral integration sites in cell lines recovered from leukemic
animals showed different bands as compared with the original injected
cells, indicating infection of host cells. Since FDCPmix cells contain
an ecotropic helper virus (MoMuLV) [23], it could have packaged
the defective MuV vector to produce an infectious virus which may
then have transformed host cells. However, when high levels of the
original MuV virus are injected into mice no myeloproliferative
disease is observed [9]. In the latter case, this may reflect a
difficulty in the ability of the injected virus to "target" to the
host cells in the sites of active hematopoiesis. This may not be
the case for the MuV-infected FDCPmix cells, which can clearly lodge
in the spleen and bone marrow and may be acting as "carriers" for
infectious viral particles, thus facilitating infection of host
hematopoietic cells. Also, it has been reported that injection of
recombinant 11-3 into normal mice leads to an increase in spleen
weight and content of CFU -S, as well as to an increase in progenitor
cells of the myeloid lineage [8, 13, 15]. Therefore, 11-3 production
by the infected cells (both donor and host) may have contributed
to the disease by stimulating stem and progenitor cells from the
recipient mice. Thus, the disease is probably multifactorial. Nonetheless,
we have clearly shown that endogenous inappropriate expression of
a growth factor gene can have profound biological effects and may
well be apart of the process leading to leukemic transformation.
References
1. Avner P, Bishop C, Amar L, Cambrou J, Hatat D, Arnaud D, Mattei
M-G (1987) Mapping the mouse X chromosome possible symmetry in the
location of a family of sequences on the mouse X and Y chromosomcs.
Developmcnt-Camb 101 [Suppl]: 107-116
2. Auffray C, Rougeon F (1980) Purification of mouse immunoglobulin
heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem
107: 303314 . Colbere-Garapin F, Horodniceanu J, Kourilsky P, Garapin
A-C (1981) A new dominant hybrid selective marker for higher eukaryotic
cells. J Mol BioI 150: 1-14
4. Feinberg AP, Vogelstein B (1984) A technique for radiolabeling
DNA restriction endonuclease fragments to high specific activity.
Anal Biochcm 137: 266-267
5. Fialkow PJ, Singer JW (1985) Tracing developmcnt and cell lineages
in human hemopoietic neoplasia. In: Weissman IL (ed) Leukemia. Dahlem
Workshop. Springer, Berlin Heidelberg New York, pp 202- 222
6. Fialkow PJ, Singer JW, Adamson JW, Vaidya K, Dow LW, Ochs J,
Moohr JW ( 1981) Acute nonlymphocytic leukemia: heterogeneity of
stem cell origin. Blood 57:1068-1073
7. Greavcs MF, Delia D, Robinson J, Sutherland R, Newman R (1981)
Exploitation of monoclonal antibodies: a "who's who" of haemopoietic
malignancy. Blood Cells 7: 257-280
8. Kindler V, Thorens B, de Kossodo S, Allet B, Eliason JF (1986)
Stimulation ofhematopoiesis in vivo by recombinant bacterial murine
intcrleukin 3. Proc Natl Acad Sci USA 83:1001-1005
9. Laker C, Kluge N, Stocking C, Just U, Franz M-J, Ostertag W,
Dexter M, Katsuno M, Spooncer E (1989) Leukemogenesis initiated
by abcrrant multi-CSF cxpression is a multi-step process and differs
in hcmatopoictic stem and precursor ccll lines. Mol Cell BioI (in
press)
10. Laker C, Stocking C, Bergholz U, Hess N, DeLamarter JF, Ostertag
W (1987) Autocrine stimulation after transfer of the granulocyte/macrophage
colony-stimulating factor gcne and autonomous growth are distinct
but inter-dependent steps in the oncogenic pathway. Proc Natl Acad
Sci USA 84: 8458- 8462
11. Lang RA, Metcalf D, Gough N, Dunn AR, Gonda TJ (1985) Expression
of a haemopoietic growth factor cDNA in a factor-dependent ccll
line results in autonomous growth and tumorigenicity. Cell43:531-542
12. Lau B, Jaeger G, Thiel E, Rodt H, Huhn D, Pachmann K, Netzel
B, Boening L, Thierfelder S, Doermer P (1979) Growth of the Reh
cell line in diffusion chambers. Evidcnce for differentiation along
the T and B-cell pathway. Scand J Haematol 23:385-392
13. Lord BJ, Molineux G, Testa NG, Kelly M, Spooncer E, Dexter
TM (1986) The kinetic response of haemopoietic precursor cells,
in vivo, to highly purified, recombinant interlcukin-3. Lymphokine
Res 5:97104
14. McMastcr GK, Carmichacl GG (1977) Analysis of singlc- and double-stranded
nucleic acids on polyacrylamide and agarose gels by using glyoxal
and acridine orange. Proc Natl Acad Sci USA 74: 4835-4839
15. Metcalf D, Begley CG, Johnson GR, Nicola NA, Lopcz AF, Williamson
DJ (1986) Effects of purified bacterially synthesized murine multi-CSF
(IL-3) on hematopoiesis in normal adult mice. Blood 68:46-57
16. Miller AD, Buttimorc C (1986) Rcdcsign of retrovirus packaging
cell lines to avoid rccombination leading to hclpcr virus production.
Mol Cell Bioi 6:2895-2902
17. Rowley JD (1985) Significance of chromosome rearrangements
in leukaemia and lymphoma. In: Weissman IL (ed) Leukemia. Dahlem
Workshop. Springer, Bcrlin Heidelberg New York, pp 179-202
18. Robcrts RA, Spoonccr E, Parkinson EK, Lord BI, Allcn TD, Dexter
TM (1987) Metabolically inactive 3T3 cells can substitute for marrow
stromal cclls to promote the proliferation and development of multipotent
haemopoietic stem cells. J Cell Physiol 132: 203- 214
19. Spooncer E, Bocttiger D, Dextcr TM (1985) Continuous in vitro
generation of mulitpotential stem ccll clones from srcinfected culturcs.
Nature 310:228-230
20. Spooncer E, Heyworth CM, Dunn A, Dcxter TM ( 1986) Self-renewal
and differ entiation of intcrleukin-3-dependent multipotent stem
cells are modulatcd by stro mal cells and serum factors. Differentiation
31: 111-118
21. Spooncer E, Lord BI, Dexter TM (1985) Defective ability to
self-renew in vitro of highly purified primitive haematopoietic
cells. Nature 316: 62-64
22. Stocking C, Kollek R, Bergholz U, Ostertag W (1985) Long terminal
repeat sequences impart hematopoietic transformation properties
to the myeloproliferative sarcoma virus. Proc Natl Acad Sci USA
82:5746-5750
23. Wyke JA, Stoker AW, Searle S, Spooncer E, Simmons P, Dexter
TM (1986) Perturbed hemopoiesis and the generation of mulitpotential
stem cell clones in src-infected bone marrow cultures is an indirect
or transient effect of the oncogene. Mol Cell BioI 6:959-963
|